Annual D&A
$118.00 K
-$25.00 K-17.48%
31 December 2023
Summary:
Cidara Therapeutics annual depreciation & amortization is currently $118.00 thousand, with the most recent change of -$25.00 thousand (-17.48%) on 31 December 2023. During the last 3 years, it has fallen by -$932.00 thousand (-88.76%). CDTX annual D&A is now -88.76% below its all-time high of $1.05 million, reached on 31 December 2020.CDTX Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$61.00 K
+$4000.00+7.02%
30 September 2024
Summary:
Cidara Therapeutics quarterly depreciation & amortization is currently $61.00 thousand, with the most recent change of +$4000.00 (+7.02%) on 30 September 2024. Over the past year, it has increased by +$39.00 thousand (+177.27%). CDTX quarterly D&A is now -92.96% below its all-time high of $866.00 thousand, reached on 31 December 2020.CDTX Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$213.00 K
+$39.00 K+22.41%
30 September 2024
Summary:
Cidara Therapeutics TTM depreciation & amortization is currently $213.00 thousand, with the most recent change of +$39.00 thousand (+22.41%) on 30 September 2024. Over the past year, it has increased by +$105.00 thousand (+97.22%). CDTX TTM D&A is now -87.37% below its all-time high of $1.69 million, reached on 30 September 2021.CDTX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CDTX Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -17.5% | +177.3% | +97.2% |
| 3 y3 years | -88.8% | -79.1% | -87.4% |
| 5 y5 years | -77.4% | -17.6% | -48.7% |
CDTX Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -88.8% | +109.6% | -79.5% | +103.0% | -87.4% | +111.0% |
| 5 y | 5 years | -88.8% | +108.5% | -93.0% | +103.0% | -87.4% | +111.0% |
| alltime | all time | -88.8% | +108.5% | -93.0% | +103.0% | -87.4% | +111.0% |
Cidara Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $61.00 K(+7.0%) | $213.00 K(+22.4%) |
| June 2024 | - | $57.00 K(+1.8%) | $174.00 K(+22.5%) |
| Mar 2024 | - | $56.00 K(+43.6%) | $142.00 K(+20.3%) |
| Dec 2023 | $118.00 K(-17.5%) | $39.00 K(+77.3%) | $118.00 K(+9.3%) |
| Sept 2023 | - | $22.00 K(-12.0%) | $108.00 K(-12.2%) |
| June 2023 | - | $25.00 K(-21.9%) | $123.00 K(-200.8%) |
| Mar 2023 | - | $32.00 K(+10.3%) | -$122.00 K(-185.3%) |
| Dec 2022 | $143.00 K(-111.6%) | $29.00 K(-21.6%) | $143.00 K(-107.4%) |
| Sept 2022 | - | $37.00 K(-116.8%) | -$1.94 M(+15.2%) |
| June 2022 | - | -$220.00 K(-174.1%) | -$1.68 M(+40.6%) |
| Mar 2022 | - | $297.00 K(-114.5%) | -$1.20 M(-2.8%) |
| Dec 2021 | -$1.23 M(-217.1%) | -$2.05 M(-802.4%) | -$1.23 M(-172.9%) |
| Sept 2021 | - | $292.00 K(+9.8%) | $1.69 M(+15.6%) |
| June 2021 | - | $266.00 K(+1.1%) | $1.46 M(+16.3%) |
| Mar 2021 | - | $263.00 K(-69.6%) | $1.25 M(+19.4%) |
| Dec 2020 | $1.05 M(-175.8%) | $866.00 K(+1253.1%) | $1.05 M(-169.8%) |
| Sept 2020 | - | $64.00 K(+4.9%) | -$1.50 M(+0.7%) |
| June 2020 | - | $61.00 K(+3.4%) | -$1.50 M(+0.7%) |
| Mar 2020 | - | $59.00 K(-103.5%) | -$1.48 M(+7.1%) |
| Dec 2019 | -$1.39 M | -$1.69 M(-2382.4%) | -$1.39 M(-433.7%) |
| Sept 2019 | - | $74.00 K(+2.8%) | $415.00 K(-13.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2019 | - | $72.00 K(-54.4%) | $478.00 K(-11.8%) |
| Mar 2019 | - | $158.00 K(+42.3%) | $542.00 K(+3.6%) |
| Dec 2018 | $523.00 K(-21.6%) | $111.00 K(-19.0%) | $523.00 K(-5.1%) |
| Sept 2018 | - | $137.00 K(+0.7%) | $551.00 K(-1.3%) |
| June 2018 | - | $136.00 K(-2.2%) | $558.00 K(-8.2%) |
| Mar 2018 | - | $139.00 K(0.0%) | $608.00 K(-8.8%) |
| Dec 2017 | $667.00 K(-8.9%) | $139.00 K(-3.5%) | $667.00 K(-6.5%) |
| Sept 2017 | - | $144.00 K(-22.6%) | $713.00 K(-4.6%) |
| June 2017 | - | $186.00 K(-6.1%) | $747.00 K(-0.5%) |
| Mar 2017 | - | $198.00 K(+7.0%) | $751.00 K(+2.6%) |
| Dec 2016 | $732.00 K(+58.8%) | $185.00 K(+3.9%) | $732.00 K(+1.8%) |
| Sept 2016 | - | $178.00 K(-6.3%) | $719.00 K(+12.2%) |
| June 2016 | - | $190.00 K(+6.1%) | $641.00 K(+16.8%) |
| Mar 2016 | - | $179.00 K(+4.1%) | $549.00 K(+19.1%) |
| Dec 2015 | $461.00 K(+157.5%) | $172.00 K(+72.0%) | $461.00 K(+21.6%) |
| Sept 2015 | - | $100.00 K(+2.0%) | $379.00 K(+8.6%) |
| June 2015 | - | $98.00 K(+7.7%) | $349.00 K(+29.3%) |
| Mar 2015 | - | $91.00 K(+1.1%) | $270.00 K(+50.8%) |
| Dec 2014 | $179.00 K | $90.00 K(+28.6%) | $179.00 K(+101.1%) |
| Sept 2014 | - | $70.00 K(+268.4%) | $89.00 K(+368.4%) |
| June 2014 | - | $19.00 K(>+9900.0%) | $19.00 K(>+9900.0%) |
| Mar 2014 | - | $0.00 | $0.00 |
FAQ
- What is Cidara Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Cidara Therapeutics?
- What is Cidara Therapeutics annual D&A year-on-year change?
- What is Cidara Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Cidara Therapeutics?
- What is Cidara Therapeutics quarterly D&A year-on-year change?
- What is Cidara Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Cidara Therapeutics?
- What is Cidara Therapeutics TTM D&A year-on-year change?
What is Cidara Therapeutics annual depreciation & amortization?
The current annual D&A of CDTX is $118.00 K
What is the all time high annual D&A for Cidara Therapeutics?
Cidara Therapeutics all-time high annual depreciation & amortization is $1.05 M
What is Cidara Therapeutics annual D&A year-on-year change?
Over the past year, CDTX annual depreciation & amortization has changed by -$25.00 K (-17.48%)
What is Cidara Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of CDTX is $61.00 K
What is the all time high quarterly D&A for Cidara Therapeutics?
Cidara Therapeutics all-time high quarterly depreciation & amortization is $866.00 K
What is Cidara Therapeutics quarterly D&A year-on-year change?
Over the past year, CDTX quarterly depreciation & amortization has changed by +$39.00 K (+177.27%)
What is Cidara Therapeutics TTM depreciation & amortization?
The current TTM D&A of CDTX is $213.00 K
What is the all time high TTM D&A for Cidara Therapeutics?
Cidara Therapeutics all-time high TTM depreciation & amortization is $1.69 M
What is Cidara Therapeutics TTM D&A year-on-year change?
Over the past year, CDTX TTM depreciation & amortization has changed by +$105.00 K (+97.22%)